At a glance
- Originator Nonindustrial source
- Class Antivirals
- Mechanism of Action HIV protease inhibitors; RNA-directed DNA polymerase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported HIV infections
Most Recent Events
- 11 Jun 1999 New profile
- 11 Jun 1999 Preclinical development for HIV infections treatment in Japan (Unknown route)